Hypertrichosis induced by latanoprost

    Toshio Demitsu, Motomu Manabe, Natsuko Harima, Toshihiro Sugiyama, Kozo Yoneda, Nariyuki Yamada
    Image of study
    TLDR Latanoprost, a glaucoma medication, caused excessive eyelid hair growth in many patients.
    In a study examining the side effects of latanoprost, a prostaglandin F2α analogue used to treat glaucoma, it was found that the drug induced hypertrichosis (excessive hair growth) in a significant number of patients. The study involved 317 Japanese patients with glaucoma (119 men and 198 women, aged 14-96 years, mean age 67 years) who were treated with topical latanoprost once a day for an average of 4 months. Of these patients, 244 (77.0%) developed hypertrichosis of the upper and/or lower eyelids, particularly on the lateral lower eyelid, with no significant sex difference in the occurrence of this side effect. Additionally, 128 patients (40.4%) experienced skin discoloration of the eyelids. Increased iris pigmentation, a side effect noted in other studies, was not remarkable in this group, possibly due to the brownish eyes common in Japanese individuals. The mechanism behind latanoprost-induced hypertrichosis is not fully understood, but it may involve increased cutaneous blood flow or altered hormonal metabolism around hair follicles. The study also suggested that latanoprost could have therapeutic potential for common hair disorders like male-pattern baldness, but further research is needed to clarify the mechanisms and develop treatment strategies for androgenic alopecia.
    View this study on jaad.org →

    Cited in this study